MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of…
Chief Executive Officer (CEO) Christian Kanstrup steps down Chief Scientific Officer Birgitte Rønø appointed interim CEO and search for new CEO…
Positive results in patients with advanced mCRC emphasize potential significance of CytoDyn’s ongoing Phase II CRC trial Dr. Benjamin Weinberg…
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus”), a clinical stage biotechnology company dedicated…
SAN FRANCISCO and BERLIN, July 01, 2025 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor…
By Chris Wood, CEO of Reveal DX Lung cancer is the leading cause of cancer-related deaths worldwide, however, advancements in…
Embedding Eleanor empowers health systems to seamlessly integrate AI across the entire patient care continuum NEW YORK, June 30, 2025…
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- Several experts are seeing…
TOKYO, June 30, 2025 /PRNewswire/ -- Alpha Fusion, Inc. ("Alpha Fusion") and Curadh MTR Inc. ("Curadh") announced plans to enter a…
Funding to accelerate platform expansion into new applications in cell-to-cell interactions and tissue STOCKHOLM, June 30, 2025 /PRNewswire/ -- Pixelgen…